This filing details stock transactions by Sean Maduck, an officer at Corcept Therapeutics Inc. On May 27, 2026, Maduck acquired 75,000 shares of Common Stock at a price of $8.27 per share, increasing his post-transaction holdings to 83,977 shares. This acquisition was linked to the exercise of a stock option. Additiona...

On May 21, 2026, Brera Holdings PLC entered into a subscription agreement with Keren Maimon for the sale of 1,149,000 Class B Ordinary Shares at a price of $4.97 per share. This transaction was conducted as a registered direct offering. Following the transaction, Keren Maimon holds 1,336,868 shares. Keren Maimon is ide...

This filing details a transaction by Robin Manherz, a director at Advantage Solutions Inc., on May 27, 2026. Manherz acquired 4,477 shares of Class A Common Stock through restricted stock units (RSUs) that are subject to vesting. The RSUs will vest on the earlier of the one-year anniversary of the grant date or the day...

Magda Marquet, a director at Immix Biopharma, Inc., was granted 6,250 restricted stock units (RSUs) on May 22, 2026. These RSUs are set to vest in full on the earlier of the one-year anniversary of the grant date or the date of the Issuer's 2027 annual meeting of stockholders, provided she continues her service. Additi...

On May 27, 2026, Marsh Andrew acquired 70,000 shares of Gevo, Inc. Common Stock. This transaction is part of a restricted stock grant that vests on the earlier of the next annual stockholder meeting or the first anniversary of the grant date, provided continuous service is maintained. Following this acquisition, Marsh ...

This filing details a Form 4 submission for Edesa Biotech, Inc. (EDSA) concerning transactions by reporting owner Marshall Patrick. On May 27, 2026, Patrick acquired 19,000 common shares with a transaction price of $0.00, as indicated by footnote F1, which refers to a grant of restricted share units under the Issuer's ...

This filing reports a transaction by Martin John Arthur, the Chief Financial Officer of Goosehead Insurance, Inc. On May 28, 2026, Mr. Arthur acquired 5,000 shares of Class A Common Stock at a price of $34.73 per share. Following this transaction, Mr. Arthur directly holds 5,000 shares of the company's Class A Common S...

Michael A. Masick, EVP/President of Americas at Brown-Forman Corp, received 611 shares of Class B Common stock on May 27, 2026, as part of a performance-based restricted stock unit award granted on July 27, 2023. The award was subject to a three-year performance period ending April 30, 2026. Concurrently, Masick surren...

This Form 4 filing reports that Christine M. McCarthy, a director of Flutter Entertainment plc (ticker: FLUT), sold 135 ordinary shares on May 28, 2026, at a price of $94.63 per share. The transaction was coded as a sale (S) and resulted in a disposition (D) of shares. Following the transaction, McCarthy now holds 1,26...

This Form 4 filing reports equity awards granted to director Michael J. McColgan of Employers Holdings, Inc. On May 28, 2026, McColgan received 2,196 restricted stock units (RSUs) that vest on May 28, 2027. The RSUs were granted at $0 per share, bringing his total common stock holdings to 18,956 shares. Additionally, o...

This filing details a Form 4 for Equillium, Inc. (EQ), reporting ownership changes for Charles Douglas McDermott. On May 28, 2026, Mr. McDermott was granted 70,000 Director Stock Options with a right to buy Common Stock. The options have an exercise price of $2.84 and vest in twelve equal monthly installments starting ...

On May 28, 2026, R. Bruce McDonald, Chairman & CEO of DANA Inc., acquired 22,808 Restricted Stock Units (RSUs) with a transaction price of $0.00. These RSUs represent the right to receive one share of Dana common stock or its cash equivalent. Dividend equivalent rights are included. The RSUs vest in full on the first a...

Daniel McFadden, Chief Operating Officer of AdaptHealth Corp., received 20,134 restricted stock units on May 27, 2026, as reported in this Form 4 filing. The shares were granted at $0.00 per share and represent equity compensation that will vest over time. Following this transaction, McFadden now holds 103,376 shares o...

Patrick McGinnis, a director at IBEX Ltd, reported the sale of 1030 common shares on May 28, 2026. The transaction was executed at a price of $31.69 per share. Following this transaction, McGinnis directly owns 5833 shares of IBEX Ltd common stock. The filing indicates this was a disposition of shares....

Timothy I. McGuire, a director at DOLLAR GENERAL CORP (DG), reported a transaction on May 28, 2026. He acquired 1647 shares of common stock under a restricted stock unit award that vests on May 28, 2027. The award had a transaction price of $0.0 per share. Following this acquisition, McGuire holds 17100.3258 shares. Ad...

This Form 4 filing discloses that Robert McQuade, a director of COMPASS Pathways plc, received an award of 21,110 stock options on May 27, 2026. The options have an exercise price of $11.85 per share and expire on May 26, 2036. The options vest in full upon the earlier of (i) the first anniversary of the grant date or ...

This Form 4 filing reports that Kristen J. McVeety, General Counsel and Secretary of CoreWeave, Inc., sold 2,246 shares of Class A Common Stock on May 27, 2026, through a pre-arranged Rule 10b5-1 trading plan. The sales occurred in six separate transactions at weighted average prices ranging from $100.29 to $105.02 per...

Michael McWatt, Managing Director, Cayman for Bank of N.T. Butterfield & Son Ltd, reported on May 27, 2026, the acquisition of 63 Restricted Stock Units - EDIP and 511 Restricted Stock Units - ELTIP. These units represent contingent rights to receive one share of common stock upon vesting. The EDIP units vest on Februa...

This filing reports a grant of 5,513 Restricted Stock Units (RSUs) to Russell Kenneth D, a director at Mechanics Bancorp, on May 28, 2026. These RSUs vest on May 28, 2027, and upon vesting, will convert into an equal number of shares of the Company's Class A common stock. The RSUs were granted at no cost to the recipie...

Nancy D. Pellegrino, a director at Mechanics Bancorp, reported a transaction on May 28, 2026. She was granted 5,513 Restricted Stock Units (RSUs), which represent a contingent right to receive one share of Class A common stock upon vesting. These RSUs vest on May 28, 2027, and do not require any payment from the holder...

This SEC Form 4 filing reports equity transactions by director Jon R. Wilcox of Mechanics Bancorp (MCHB). On May 27, 2026, 3,301 restricted stock units (RSUs) vested and converted into Class A common stock, which Wilcox acquired at $0 per share. Following this transaction, he now holds 13,204 shares of Class A common s...

This SEC filing details a transaction by Eric J. Meilstrup, CEO of LCNB Corp. On May 28, 2026, Meilstrup acquired 400 shares of LCNB Corp Common Stock at a price of $16.945 per share. Following this transaction, Meilstrup directly owns 53,478 shares of the company's stock. The filing was made on Form 4, signed on May 2...

This Form 4 filing details stock transactions by Hunter Middleton, Chief Product Officer at 8X8 INC /DE/. On May 27, 2026, Middleton acquired 66,600 shares of Common Stock through the vesting of performance share units (PSUs) awarded on September 15, 2024. Concurrently, 33,886 shares were withheld to cover tax liabilit...

This filing details a Form 4 submission for Paul Michael Miele, SVP, Chief Commercial Officer of ACCURAY INC, on May 29, 2026. The transaction involves the acquisition of 650,000 Restricted Stock Units (RSUs) with a price of $0.00 per share. These RSUs are contingent on receiving one share of the Issuer's common stock ...

This Form 4 filing details a transaction by Andrew Craig Miller, a director at Alto Neuroscience, Inc. On May 27, 2026, Mr. Miller was granted 26,000 stock options for common stock, with a purchase price of $0.00 per share, as per the company's Non-Employee Director Compensation Policy. These options vest in 36 equal m...